Cargando…
Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing
Renal transplantation is the treatment of choice for patients with end-stage renal disease. Because kidneys are the primary excretory organs for various drugs/drug metabolites, changes in renal graft function would significantly alter the clearance and exposure of renally secreted drugs. Renal allog...
Autores principales: | Kalluri, Hari V., Sood, Puneet, Zhao, Wenchen, Randhawa, Parmjeet S., Tevar, Amit D., Hariharan, Sundaram, Humar, Abhinav, Venkataramanan, Raman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531749/ https://www.ncbi.nlm.nih.gov/pubmed/33062845 http://dx.doi.org/10.1097/TXD.0000000000001001 |
Ejemplares similares
-
HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor Transplantation
por: Krishnan, Nithya, et al.
Publicado: (2021) -
Impact of Subclinical and Clinical Kidney Allograft Rejection Within 1 Year Posttransplantation Among Compatible Transplant With Steroid Withdrawal Protocol
por: Owoyemi, Itunu, et al.
Publicado: (2021) -
Antithrombin Perfluorocarbon Nanoparticles Improve Renal Allograft Function in a Murine Deceased Criteria Donor Model
por: Vemuri, Chandu, et al.
Publicado: (2018) -
Comparing Emotional Adjustment of Living-donor and Deceased-donor Kidney Transplant Patients
por: Lai, Yousheng Lester, et al.
Publicado: (2020) -
High Calcineurin Inhibitor Intrapatient Variability Is Associated With Renal Allograft Inflammation, Chronicity, and Graft Loss
por: Sharma, Akhil, et al.
Publicado: (2019)